Chengcheng Hao

472 total citations
18 papers, 353 citations indexed

About

Chengcheng Hao is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Chengcheng Hao has authored 18 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Rheumatology. Recurrent topics in Chengcheng Hao's work include Bone and Dental Protein Studies (5 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Chengcheng Hao is often cited by papers focused on Bone and Dental Protein Studies (5 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Chengcheng Hao collaborates with scholars based in China, United Kingdom and United States. Chengcheng Hao's co-authors include Wen G. Jiang, Shan Cheng, Wenbin Li, Yuxin Cui, Yanan Gu, Jane Lane, Shuxian Wei, Yan Li, Zhaojie Wang and Huishan Zhao and has published in prestigious journals such as Applied Catalysis B: Environmental, Scientific Reports and Nanoscale.

In The Last Decade

Chengcheng Hao

18 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengcheng Hao China 12 124 84 82 60 51 18 353
Li Deng China 14 198 1.6× 52 0.6× 75 0.9× 81 1.4× 46 0.9× 35 483
Paolo Colomba Italy 16 169 1.4× 84 1.0× 100 1.2× 69 1.1× 18 0.4× 47 604
Jiyun Zhang China 12 117 0.9× 33 0.4× 38 0.5× 49 0.8× 66 1.3× 37 399
Takuhito Narita Japan 8 175 1.4× 85 1.0× 33 0.4× 118 2.0× 100 2.0× 12 578
Yi Ouyang China 14 188 1.5× 77 0.9× 58 0.7× 111 1.9× 78 1.5× 49 576
Mourad Bekhouche France 14 231 1.9× 94 1.1× 46 0.6× 117 1.9× 32 0.6× 19 609
Harish Srinivasan India 7 131 1.1× 40 0.5× 22 0.3× 96 1.6× 104 2.0× 7 354
Hiroki Mizuno Japan 12 154 1.2× 64 0.8× 19 0.2× 46 0.8× 26 0.5× 23 374
Yuanyuan Shi China 13 181 1.5× 34 0.4× 51 0.6× 113 1.9× 45 0.9× 18 411
Yi-Wen Chang Taiwan 9 253 2.0× 122 1.5× 22 0.3× 79 1.3× 13 0.3× 15 460

Countries citing papers authored by Chengcheng Hao

Since Specialization
Citations

This map shows the geographic impact of Chengcheng Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengcheng Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengcheng Hao more than expected).

Fields of papers citing papers by Chengcheng Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengcheng Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengcheng Hao. The network helps show where Chengcheng Hao may publish in the future.

Co-authorship network of co-authors of Chengcheng Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Chengcheng Hao. A scholar is included among the top collaborators of Chengcheng Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengcheng Hao. Chengcheng Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Jinpeng, Chengcheng Hao, Hongyu Chen, et al.. (2025). Alkali Metal-Functionalized Covalent Organic Frameworks for CO2 Adsorption and CO2/N2 Separation. ACS Applied Polymer Materials. 7(3). 1729–1740. 4 indexed citations
2.
Chen, Xiao Dong, Zhaojie Wang, Shoufu Cao, et al.. (2024). Steering elementary steps towards advanced alkaline hydrogen evolution via a sweet marriage of O-defected NiO and Cu. Applied Catalysis B: Environmental. 357. 124295–124295. 8 indexed citations
3.
Chen, Xiaohong, Shoufu Cao, Xiaojing Lin, et al.. (2023). Construction of pH-universal hydrogen evolution freeway in MoO3-MoNi4@Cu core–shell nanowires via synergetic electronic and geometric effect. Nano Research. 16(10). 12253–12262. 14 indexed citations
4.
Hao, Chengcheng, Jane Lane, & Wen G. Jiang. (2023). Osteopontin and Cancer: Insights into Its Role in Drug Resistance. Biomedicines. 11(1). 197–197. 22 indexed citations
5.
Hu, Yuying, Hongyu Chen, Meng Chen, et al.. (2023). Graphdiyne supported Ag–Cu tandem catalytic scheme for electrocatalytic reduction of CO2to C2+products. Nanoscale. 15(5). 2106–2113. 21 indexed citations
6.
Liu, Siyuan, Chengcheng Hao, Sen Liu, et al.. (2023). Nanoporous Fluorinated Covalent Organic Framework for Efficient C2H2/CO2 Separation with High C2H2 Uptake. ACS Applied Nano Materials. 6(13). 12124–12131. 16 indexed citations
7.
Hao, Chengcheng, Yuxin Cui, Jane Lane, et al.. (2021). Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer. Cells. 10(7). 1820–1820. 8 indexed citations
8.
Hao, Chengcheng, Gang Chen, Huishan Zhao, et al.. (2020). PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis. Frontiers in Oncology. 10. 1015–1015. 69 indexed citations
9.
Li, Yan, Chengcheng Hao, Shan Li, et al.. (2020). Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature. Clinical Laboratory. 66(08/2020). 3 indexed citations
10.
Hao, Chengcheng, Yuxin Cui, Siyuan Chang, et al.. (2019). OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase. Scientific Reports. 9(1). 18101–18101. 17 indexed citations
11.
Hao, Chengcheng, et al.. (2019). Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma. Therapeutic Advances in Respiratory Disease. 13. 3271601137–3271601137. 32 indexed citations
12.
Hao, Chengcheng, et al.. (2017). Human osteopontin: Potential clinical applications in cancer (Review). International Journal of Molecular Medicine. 39(6). 1327–1337. 69 indexed citations
13.
Hao, Chengcheng, Yuxin Cui, Mu Hu, et al.. (2017). OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells In Vitro. Anticancer Research. 37(5). 2245–2254. 15 indexed citations
14.
Du, Guifang, Yanan Gu, Chengcheng Hao, et al.. (2016). The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. Oncotarget. 7(20). 29440–29453. 15 indexed citations
15.
Hao, Chengcheng, Zhiyan Wang, Yanan Gu, Wen G. Jiang, & Shan Cheng. (2016). Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis. BioMed Research International. 2016. 1–8. 19 indexed citations
16.
Du, Guifang, Chengcheng Hao, Yanan Gu, et al.. (2016). A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.. PubMed. 36(3). 1165–73. 11 indexed citations
17.
Gu, Yanan, Hefen Yu, Chengcheng Hao, et al.. (2016). NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Oncotarget. 8(5). 7753–7765. 8 indexed citations
18.
Du, Guifang, Xiaomei Yang, Mu Hu, et al.. (2015). Designing a novel high-throughput AlphaLISA assay to quantify plasma NHERF1 as a non-small cell lung cancer biomarker. RSC Advances. 5(102). 84164–84171. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026